Results 261 to 269 of about 52,625 (269)

Homologous Recombination Deficiency (HRD) in Hematological Malignancies

Blood, 2022
Nikhil Sahajpal, Vamsi K. Kota, Anand P. Jillella, Ashis Mondal, Ravindra Kolhe   +4 more
openaire   +1 more source

Homologous recombination deficiency real-time clinical assays, ready or not?

Gynecologic Oncology, 2020
Katherine Fuh, Mary M Mullen, Elizabeth H Stover   +2 more
exaly  

Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors

European Journal of Cancer, 2022
Alexis Trécourt, Alexandra Leary, Julien Peron   +2 more
exaly  

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

Cancer Cell, 2018
Chaoyang Sun, Jun Yin, Kang Jin Jeong
exaly  

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy

Annals of Oncology, 2011
L Mulder, M T F D Vrancken Peeters, M J Van De Vijver   +2 more
exaly  

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

Nature Reviews Molecular Cell Biology, 2010
Mary Ellen Moynahan, Maria Jasin, Jasin Maria   +2 more
exaly  

Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer

Trends in Molecular Medicine, 2017
Grainne M O'Kane, Steven Gallinger
exaly  

How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature

Frontiers in Oncology
Anna Biasioli, Claudia Andreetta, Stefano Restaino   +2 more
exaly  

Perspectives on Homologous Recombination Repair Deficiency (HRD)

Advances in Molecular Pathology
Kathleen Gwilliam, Kendall E. Martin, Scott A. Turner   +2 more
openaire   +1 more source